Item 1. Financial Statements.


The Financial Statements of the Registrant required to be filed with this 10-QSB Quarterly Report were prepared by management, and commence on the following page, together with Related Notes. In the opinion of management, the Financial Statements fairly present the financial condition of the Registrant.







2











ZALDIVA, INC.



FINANCIAL STATEMENTS



June 30, 2008 and September 30, 2007




3











C O N T E N T S



Balance Sheets…………………………………………………….………………………4


Statements of Operations……………….………….…………….………………………..5


Statements of Stockholders’ Equity (Deficit)…….…………….…………………………6


Statements of Cash Flows…………………………………………………….…...……... 7


Notes to the Financial Statements…………………..……………………………………..8







4




ZALDIVA, INC.

Balance Sheets


ASSETS


 

 

 

 

June 30,

 

September 30,

 

 

 

 

2008

 

2007

CURRENT ASSETS

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

$

     24,957

 

$

           77,769

 

Inventories

 

 80,616

 

 

           84,973

 

Prepaid expenses

 

737

 

 

             5,000

 

 

 

 

 

 

 

 

 

 

 

Total Current Assets

 

106,310

 

 

          167,742

 

 

 

 

 

 

 

 

 

PROPERTY & EQUIPMENT, Net

 

653,945

 

 

          668,906

 

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

 $

760,255

 

 $

          836,648

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

$

13,314

 

$

           15,616

 

Deferred revenue

 

4,089

 

 

             4,283

 

Convertible preferred stock; $0.001 par value,

 

 

 

 

 

 

   20,000,000 shares authorized, 500,000 shares

 

 

 

 

 

 

   issued and outstanding, respectively

 

          588,235

 

 

          588,235

 

 

 

 

 

 

 

 

 

 

 

Total Current Liabilities

 

605,638

 

 

          608,134

 

 

 

 

 

 

 

 

 

STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock; $0.001 par value, 50,000,000

 

 

 

 

 

 

   shares authorized, 8,163,332 shares issued and

 

 

 

 

 

 

   outstanding, respectively

 

             8,163

 

 

             8,163

 

Additional paid-in capital

 

1,591,235

 

 

       1,247,477

 

Accumulated deficit

 

(1,444,781)

 

 

(1,027,126)

 

 

 

 

 

 

 

 

 

 

 

Total Stockholders' Equity

 

154,617

 

 

          228,514

 

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

$

760,255

 

$

          836,648

 

 

 

 

 

 

 

 

 



The accompanying condensed notes are an integral part of these interim financial statements.




5




ZALDIVA, INC.

Statements of Operations

(Unaudited)


 

 

 

For the Three Months Ended

 

For the Nine Months Ended

 

 

 

June 30,

 

June 30,

 

 

 

2008

 

2007

 

2008

 

2007

 

 

 

 

 

 

 

 

 

 

 

 

 

 

REVENUES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product Sales

$

77,887

 

$

43,763

 

$

195,884

 

$

100,790

 

Internet Services

 

-

 

 

8,614

 

 

       16,119

 

 

        17,038

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Revenues

   

77,887

   

   

52,377

 

   

212,003

   

   

117,828

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COST OF GOODS SOLD

 

43,303

 

 

23,313

 

 

107,100

 

 

58,737

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Profit

   

34,584

   

   

29,064

 

   

104,903

   

   

59,091

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OPERATING EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative expenses

 

152,093

 

 

99,844

 

 

460,949

 

 

288,039

 

Advertising expense

 

7,381

 

 

6,042

 

 

16,026

 

 

18,538

 

Website development expenses

 

4,310

 

 

1,269

 

 

13,921

 

 

1,414

 

Depreciation expense

 

        4,987

 

 

        4,987

 

 

14,961

 

 

15,300

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Operating Expenses

 

168,771

   

 

112,142

 

 

505,859

   

 

323,291

 

 

 

 

   

 

 

 

 

 

   

 

 

 

 

 

OPERATING LOSS

 

(134,187)

 

 

(83,078)

 

 

(400,956)

 

 

(264,200)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OTHER INCOME (EXPENSE)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

19

 

 

155

 

 

948

 

 

650

 

Interest expense

 

(6,763)

 

 

       (8,000)

 

 

(17,647)

 

 

(24,000)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Other Income

 

 

 

 

 

 

 

 

 

 

 

 

 

  (Expense)

 

(6,744)

 

 

(7,845)

 

 

(16,699)

 

 

(23,350)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET LOSS

$

(140,931)

 

$

(90,923)

 

$

(417,655)

 

$

(287,550)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BASIC AND DILUTED  

 

 

 

 

 

 

 

 

 

 

 

 

  LOSS PER SHARE

$

(0.02)

 

$

(0.01)

 

$

(0.05)

 

$

(0.04)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

WEIGHTED AVERAGE  

 

 

 

 

 

 

 

 

 

 

 

 

  NUMBER OF SHARES

 

 

 

 

 

 

 

 

 

 

 

 

  OUTSTANDING

 

8,163,332

 

 

7,182,024

 

 

8,163,332

 

 

7,122,684

 

 

 

 

 

 

 

 

 

 

 

 

 

 


The accompanying condensed notes are an integral part of these interim financial statements.



6





ZALDIVA, INC.

Statements of Stockholders' Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

Total

 

Common Stock

 

Paid-In

 

Accumulated

 

Stockholders'

 

Shares

 

Amount

 

Capital

 

Deficit

 

Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, September 30, 2006

6,867,858

 

$

6,868

 

$

443,884

 

$

(637,811)

 

$

(187,059)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrants exercised

    610,000

 

 

    610

 

 

    152,720

 

 

                -

 

 

   153,330

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contributed capital

-

 

 

-

 

 

4,835

 

 

-

 

 

4,835

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Conversion of convertible

 

 

 

 

 

 

 

 

 

 

 

 

 

   preferred stock

 357,142

 

 

357

 

 

352,584

 

 

-

 

 

352,941

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued for services

300,000

 

 

 300

 

 

125,700

 

 

-

 

 

   126,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued for dividends

28,332

 

 

28

 

 

14,972

 

 

-

 

 

     15,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of warrants granted

-

 

 

-

 

 

    152,782

 

 

-

 

 

   152,782

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss for the year ended

 

 

 

 

 

 

 

 

 

 

 

 

 

   September 30, 2007

               -

 

 

-

 

 

               -

 

 

     (389,315)

 

 

  (389,315)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, September 30, 2007

  8,163,332

 

 

  8,163

 

 

  1,247,477

 

 

  (1,027,126)

 

 

   228,514

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of warrants granted

               -

 

 

-

 

 

    343,758

 

 

                -

 

 

   343,758

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss for the nine months ended

 

 

 

 

 

 

 

 

 

 

 

 

 

   June 30, 2008 (unaudited)

               -

 

 

 -

 

 

               -

 

 

     (417,655)

 

 

  (417,655)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, June 30,

 

 

 

 

 

 

 

 

 

 

 

 

 

   2008 (unaudited)

  8,163,332

 

$

8,163

 

$

  1,591,235

 

$

  (1,444,781)

 

$

   154,617

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 




7





ZALDIVA, INC.

Statements of Cash Flows

(Unaudited)


 

 

 

 

For the Nine Months Ended

 

 

 

 

June 30,

 

 

 

 

2008

 

2007

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

Net income (loss)

$

(417,655)

 

$

(287,550)

 

Adjustments to reconcile net loss to net cash

 

 

 

 

 

 

  used by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

14,961

 

 

15,300

 

 

Fair value of warrants

 

343,758

 

 

-

 

 

Non cash interest expense

 

-

 

 

16,000

 

 

Common stock issued for services

 

-

 

 

202,391

 

Changes in operating assets and liabilities

 

 

 

 

 

 

 

(Increase) decrease in inventory

 

4,357

 

 

21,898

 

 

(Increase) decrease in prepaid expenses

 

4,263

 

 

640

 

 

Increase (decrease) in current liabilities

 

(2,302)

 

 

14,080

 

 

Increase (decrease) in unearned revenue

 

(194)

 

 

(220)

 

 

 

 

 

 

 

 

 

 

 

 

Net Cash Used by Operating Activities

 

(52,812)

 

 

(17,461)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Purchase) of building improvements

 

-

 

 

(114,196)

 

 

 

 

 

 

 

 

 

 

 

 

Net Cash Used by Investing Activities

 

-

 

 

(114,196)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contributed capital

 

-

 

 

75,500

 

 

 

 

 

 

 

 

 

 

 

 

Net Cash Provided by Investing Activities

 

-

 

 

75,500

 

 

 

 

 

 

 

 

 

 

 

NET INCREASE (DECREASE) IN CASH

   

(52,812)

 

   

(56,157)

 

 

 

 

 

 

 

 

 

 

 

CASH AT BEGINNING OF PERIOD

   

        77,769

 

   

        86,183

 

 

 

 

 

 

 

 

 

 

 

CASH AT END OF PERIOD

$

24,957

 

$

30,026

 

 

 

 

 

   

 

 

   

SUPPLIMENTAL DISCLOSURES OF

 

 

 

 

 

 

CASH FLOW INFORMATION

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CASH PAID FOR:

 

 

 

 

 

 

 

Interest

 $

10,001

 

 $

-

 

 

Income Taxes

 $

-

 

 $

-

The accompanying condensed notes are an integral part of these interim financial statements.



8




ZALDIVA, INC.

Notes to the Condensed Financial Statements

June 30, 2008 and September 30, 2007

 

NOTE 1 -

CONDENSED FINANCIAL STATEMENTS


The accompanying financial statements have been prepared by the Company without audit.  In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows at June 30, 2008, and for all periods presented herein, have been made.


Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.  It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s September 30, 2007 audited financial statements.  The results of operations for the periods ended June 30, 2008 and 2007 are not necessarily indicative of the operating results for the full years.


NOTE 2 -

GOING CONCERN


The Company’s financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.


In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan is to obtain such resources for the Company by obtaining capital from management and significant shareholders sufficient to meet its minimal operating expenses and seeking equity and/or debt financing. However management cannot provide any assurances that the Company will be successful in accomplishing any of its plans.


The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.





9




NOTE 3 - IMPACT OF RECENT ACCOUNTING PRONOUNCEMENTS


In March 2008, the FSAB issued SFAS No. 161, “Disclosures about Derivative Instruments and Hedging Activities.”  SFAS 161 is intended to improve financial reporting about derivative instruments and hedging activities by requiring enhanced disclosures to enable investors to better understand their effects on an entity's financial position, financial performance, and cash flows.  SFAS 161 is effective for financial statements issued for fiscal years and interim periods beginning after November 15, 2008, with early application encouraged.  We do not anticipate a material impact upon adoption.


In December 2007, the FASB issued SFAS 160, “Noncontrolling interests in Consolidated Financial Statements – an amendment of ARB No. 51”. This Statement amends ARB 51 to establish accounting and reporting standards for the noncontrolling interest in a subsidiary and for the deconsolidation of a subsidiary. It clarifies that a noncontrolling interest in a subsidiary is an ownership interest in the consolidated entity that should be reported as equity in the consolidated financial statements. This Statement is effective for fiscal years beginning on or after December 15, 2008. Early adoption is not permitted. Management is currently evaluating the effects of this statement, but it is not expected to have any impact on the Company’s financial statements.


In February 2007 , the FASB issued SFAS 159, “The Fair Value Option for Financial Assets and Financial Liabilities. SFAS 159 creates a fair value option allowing an entity to irrevocably elect fair value as the initial and subsequent measurement attribute for certain financial assets and financial liabilities, with changes in fair value recognized in earnings as they occur. SFAS 159 also requires an entity to report those financial assets and financial liabilities measured at fair value in a manner that separates those reported fair values from the carrying amounts of assets and liabilities measured using another measurement attribute on the face of the statement of financial position. Lastly, SFAS 159 requires an entity to provide information that would allow users to understand the effect on earnings of changes in the fair value on those instruments selected for the fair value election. SFAS 159 is effective for fiscal years beginning after November 15, 2007 with early adoption permitted. The Company is continuing to evaluate SFAS 159 and to assess the impact on its results of operations and financial condition if an election is made to adopt the standard.

 

In September 2006, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 157, “Fair Value Measurements” which defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles (GAAP), and expands disclosures about fair value measurements. Where applicable, SFAS No. 157 simplifies and codifies related guidance within GAAP and does not require any new fair value measurements. SFAS No. 157 is effective for financial statements issued for fiscal years beginning after November 15, 2007, and interim periods within those fiscal years. Earlier adoption is encouraged. The Company does not expect the adoption of SFAS No. 157 to have a significant effect on its financial position or results of operation.



10






Item 2. Management’s Discussion and Analysis or Plan of Operation.


Results of Operation


For The Three Months Ended June 30, 2008 Compared to The Three Months Ended June 30, 2007.


During the quarterly period ended June 30, 2008, we received total revenues of $77,887. This compares to total revenues of $52,377 in the quarterly period ended June 30, 2007.  Costs of sales during these periods were $43,303 and $23,313 respectively.


Operating expenses increased to $168,771 during the quarterly period ended June 30, 2008, from $112,142 in the year-ago period.  For the three months ended June 30, 2008, we had a net loss of $140,931, as compared to a net loss of $90,923 during the June 30, 2007, period.  Included in the net loss for 2008 is $114,586 from the amortization of warrants granted in 2007 to our officers and directors. Included in the net loss for 2007 was $76,391 for these warrants. Excluding these non cash expenses our loss for the three months ended June 30, 2008 and 2007 would have been only $26,345 and $14,532, respectively.


For The Nine Months Ended June 30, 2008 Compared to The Nine Months Ended June 30, 2007.


During the nine months ended June 30, 2008, we received total revenues of $212,003. This compares to total revenues of $117,828 in the same period ended June 30, 2007.  Costs of sales during these periods were $107,100 and $58,737 respectively.


Operating expenses increased to $505,859 during the nine months ended June 30, 2008, from $323,291 in the year-ago period.  For the nine months ended June 30, 2008, we had a net loss of $417,655, as compared to a net loss of $287,550 during the nine months ended June 30, 2007, period.  Included in the net loss for 2008 is $343,758 from the amortization of warrants granted in 2007 to our officers and directors. Included in the net loss for 2007 was $76,391 for these war